"Icon Cancer Centre Hobart offers a full range of cancer treatments and is located 500m from Hobart Private Hospital with entrance off Campbell Street. Treatment options include radiation therapy, chemotherapy, immunotherapy and targeted therapies alongside access to clinical trials, pharmacy, genetic counselling and allied health services. Radiation therapy techniques include stereotactic radiation therapy and deep inspiration breath hold. There is no wait list, ensuring patients receive immediate access to consultation and treatment. The centre has a team of caring medical oncologists, radiation oncologists, oncology nurses and administrative staff. Free on-site parking is available with access off Campbell and Melville Streets."

During the past decade, Icon Cancer Centre Hobart conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Icon Cancer Centre Hobart" #1 sponsor was "Gilead Sciences" with 3 trials, followed by "Eli Lilly and Company" with 2 trials sponsored, "Breast Cancer Trials, Australia and New Zealand" with 1 trials sponsored, "Jules Bordet Institute" with 1 trials sponsored and "Melanoma and Skin Cancer Trials Limited" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Icon Cancer Centre Hobart" #1 collaborator was "Australian and New Zealand Urogenital and Prostate Cancer Trials Group" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Canadian Cancer Trials Group" with 1 trials as a collaborator and "Cancer Trials Ireland" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Icon Cancer Centre Hobart" are "HER2-positive Breast Cancer" (2 trials), "Triple Negative Breast Cancer" (2 trials), "Abiraterone Acetate" (1 trials), "Androgens" (1 trials) and "Antineoplastic Agents" (1 trials). Many other conditions were trialed in "Icon Cancer Centre Hobart" in a lesser frequency.

Most popular intervention types in "Icon Cancer Centre Hobart" are "Drug" (10 trials), "Biological" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (3 trials), "Pembrolizumab" (3 trials), "Sacituzumab Govitecan-hziy" (3 trials), "Abemaciclib" (2 trials) and "Carboplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Icon Cancer Centre Hobart" are 8 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Icon Cancer Centre Hobart". undefined are not yet recruiting, 8 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Icon Cancer Centre Hobart, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Icon Cancer Centre Hobart, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".